More consistent evidence supports EMILIN-1’s protective role in head and neck squamous cell carcinoma (HNSCC), where reduced expression correlates with second primary malignancies [67] and poor prognosis in HPV-associated cases [68]. The gene discussed is EMILIN1; the disease is head and neck squamous cell carcinoma.